Compare FLGT & OMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FLGT | OMDA |
|---|---|---|
| Founded | 2011 | 2011 |
| Country | United States | United States |
| Employees | N/A | 868 |
| Industry | Medical Specialities | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 867.4M | 711.1M |
| IPO Year | 2016 | N/A |
| Metric | FLGT | OMDA |
|---|---|---|
| Price | $14.77 | $14.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 3 | 10 |
| Target Price | ★ $28.33 | $24.00 |
| AVG Volume (30 Days) | 607.9K | ★ 1.5M |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $18,730,000.00 | N/A |
| Revenue This Year | $10.66 | $22.07 |
| Revenue Next Year | $12.17 | $19.75 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $13.46 | $10.28 |
| 52 Week High | $31.04 | $26.92 |
| Indicator | FLGT | OMDA |
|---|---|---|
| Relative Strength Index (RSI) | 25.46 | 60.08 |
| Support Level | $13.46 | $10.28 |
| Resistance Level | $22.97 | $16.93 |
| Average True Range (ATR) | 0.96 | 0.84 |
| MACD | -0.14 | 0.31 |
| Stochastic Oscillator | 11.84 | 86.01 |
Fulgent Genetics Inc is a technology company that focuses on genetic testing to provide physicians with clinically actionable diagnostic information. The company is engaged in laboratory services business and a therapeutic development business. The laboratory services business which generates key revenue includes, technical laboratory services and professional interpretation of laboratory results by licensed physicians. Its therapeutic development business is focused on developing drug candidates for treating a broad range of cancers. The geographical segments are the United States, which generates the vast majority of the revenue; and Foreign.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.